Pain and Emotional Expression in Children With Autism or Mental Retardation
NCT ID: NCT01043822
Last Updated: 2010-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
138 participants
OBSERVATIONAL
2009-12-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Child aged 3 to 6 years old
* Diagnosis of autistic disorder established according a pluridisciplinary staff (ICD-10 criteria, Vineland scales, ADOS, etc.)
* Admitted to children's neuropediatrics or genetics department for a venepuncture
Control group mental retardation:
* Child aged 3 to 6 years old .
* Diagnosis of mental retardation established according a pluridisciplinary staff (ICD-10 criteria, Vineland scales, ADOS, etc.)
* Admitted to neuropediatric or genetic department for a venepuncture
Control group without developmental disorder :
* Child aged 18 months to 5 years old.
* Admitted to pediatrics department for a venepuncture
18 Months
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University Hospital Montpellier
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amaria BAGHDADLI, Pr
Role: PRINCIPAL_INVESTIGATOR
Montpellier University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montpellier University Hospital
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Amaria BAGHDADLI, Pr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UF8481
Identifier Type: -
Identifier Source: org_study_id